Inflammatory pathways of importance for management of inflammatory bowel disease

Medicin og biovidenskab

• Inflammatory Bowel Diseases 100%
• Tumor Necrosis Factor Inhibitors 38%
• Ulcerative Colitis 31%
• Crohn Disease 30%
• Therapeutics 17%
• Leukocytes 16%
• Tumor Necrosis Factor-alpha 15%
• Janus Kinase Inhibitors 14%
• Critical Pathways 12%
• Vascular Endothelium 11%
• Interleukin-12 10%
• Neutralizing Antibodies 10%
• Integrins 9%
• Gastrointestinal Tract 9%
• Pharmaceutical Preparations 8%
• Mucous Membrane 8%
• Clinical Trials 6%
• Biomarkers 6%
• Cytokines 6%
• Inflammation 6%
• Antibodies 5%